This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International APAC
August 31- September 2, 2026
Marina Bay SandsSingapore

Dr. Sumiko Hasegawa
Associate Director, Downstream Process Development at Takeda Pharmaceutical Company Limited
Speaker

Profile

Sumiko Hasegawa is an Associate Director of Downstream Process Development in Biotherapeutics Process Development Takeda Pharmaceutical Company Ltd. She has more than 15 years of experience in downstream process development for biologics, with a focus on monoclonal antibodies and mAb-like proteins, technology transfer to manufacturing sites, and regulatory submission support. She holds a Master’s degree in Biotechnology Engineering and a Ph.D. in Bioscience. In her current role, she leads downstream development activities supporting both early- and late-stage biotherapeutic programs and contributes to the advancement of robust and scalable manufacturing processes.

Agenda Sessions

  • Accelerating Development Timelines Through Platform Technologies

    13:30